Business
“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald
Australian health authorities have backed AstraZeneca’s vaccine despite South Africa’s decision to pause roll-out of the jab, after early clinical data showed it…
It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…
-
Business17 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
General19 hours agoFootballers and movie stars: PM’s Shanghai tourism push
-
Noosa News17 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard
-
General16 hours ago‘Hidden and radical’ power of First Nations women unlocked in big hART’s Punkaliyarra project